Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hartmann

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood|May 27, 2026
Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programsMariam Hakobyan, Jens Langstein, María José Ramos Medina, et al.
Nature Communications|January 3, 2024
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusionsJulia Schöpf, Sebastian Uhrig, Christoph E Heilig, et al.
Nature Communications|October 28, 2020
Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bonePavlo Lutsik, Annika Baude, Daniela Mancarella, et al.
Nucleic Acids Research|October 21, 2025
Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standardYu-Yu Lin, Kersten Breuer, Dieter Weichenhan, et al.
Nature Communications|December 21, 2017
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemiaDaniel B Lipka, Tania Witte, Reka Toth, et al.
Blood Cancer Discovery|December 5, 2025
Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic LeukemiaMark Hartmann, Maximilian Schönung, Jovana Rajak, et al.
Blood Cancer Discovery|March 31, 2025
Enhancer hijacking discovery in acute myeloid leukemia by pyjacker identifies MNX1 activation via deletion 7qEtienne Sollier, Anna Riedel, Umut H Toprak, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood|May 27, 2026
Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programsMariam Hakobyan, Jens Langstein, María José Ramos Medina, et al.
Nature Communications|January 3, 2024
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusionsJulia Schöpf, Sebastian Uhrig, Christoph E Heilig, et al.
Nature Communications|October 28, 2020
Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bonePavlo Lutsik, Annika Baude, Daniela Mancarella, et al.
Nucleic Acids Research|October 21, 2025
Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standardYu-Yu Lin, Kersten Breuer, Dieter Weichenhan, et al.
Nature Communications|December 21, 2017
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemiaDaniel B Lipka, Tania Witte, Reka Toth, et al.
Blood Cancer Discovery|December 5, 2025
Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic LeukemiaMark Hartmann, Maximilian Schönung, Jovana Rajak, et al.
Blood Cancer Discovery|March 31, 2025
Enhancer hijacking discovery in acute myeloid leukemia by pyjacker identifies MNX1 activation via deletion 7qEtienne Sollier, Anna Riedel, Umut H Toprak, et al.
Pageof 2